GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Short Percentage of Float

Microbix Biosystems (TSX:MBX) Short Percentage of Float


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Microbix Biosystems's Short Percentage of Float

For the Biotechnology subindustry, Microbix Biosystems's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbix Biosystems's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Short Percentage of Float falls into.


Microbix Biosystems (TSX:MBX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Short Percentage of Float
Comparable Companies
TSX:HBP TSX:BCT TSX:MSCL XCNQ:DTC XCNQ:GLAB TSXV:NRX TSXV:TTI TSXV:GSD NEOE:BMND TSXV:COV OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
MBXBF:USA
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Website
https://www.microbix.com
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Executives
James Stuart Currie Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines